Adalimumab 61434-0020
Product NDC
61434-0020- Manufacturer
- Catalent Indiana, Llc
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- January 1, 2025
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab | 40 mg/.8mL |
Packaging Options(1)
1440 SYRINGE in 1 CASE (61434-020-00) / .8 mL in 1 SYRINGE